CHEMANEX PLC
INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31.03.2025
CHEMANEX PLC
FOR THE PERIOD ENDED 30THJUNE 2024
CHEMANEX PLC
Corporate Information
Name of Company Chemanex PLC
Legal Status A Public Quoted Company with Limited Liability Under the provisions of Companies Act No 7 of 2007
Registered Office No 199, Kew Road Colombo 02
Date of Incorporation 28 August 1974 Company Registration Number PQ 64
Directors P R Saldin - Chairman
R P Bandaranayake (appointed w.e.f.25 thSeptember 2024 ) E M M Boyagoda (resigned w.e.f.31 stDecember 2024 )
S A B Ekanayake
T K D A P Samarasinghe (appointed w.e.f.25 thSeptember 2024 ) P A Seresinhe
Company Secretary S A B P W M R R W T Wegodapola
Auditors Ernst & Young
Chartered Accountants
Rotunda Towers, No.109, Galle Road, P.O.Box 101, Colombo 03.
Legal Advisers Nithya Partners Attorneys-at - Law
97A, Galle Road, Colombo 3.
Heritage Partners Attorneys-at - Law
04, Malasekara Pedesa, Colombo 07,
Subsidiary Companies Chemanex Exports (Pvt) Limited (Non operating)
Chemcel (Pvt) Limited (Non operating)
Bankers Commercial Bank of Ceylon PLC Standard Chartered Bank
Hatton National Bank PLC Nations Trust Bank PLC
Quarter ended 31 March | Twelve months ended 31 March | ||||||||
2025 | 2024 | Variance % | 2025 | 2024 | Variance % | ||||
CHEMANEX PLC STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
(In Rs. '000) Revenue | Note 1 | 240,444 | 224,178 | 7 | 873,516 | 788,965 | 11 |
Cost of sales | (173,226) | (177,897) | (3) | (621,461) | (600,404) | 4 | |
Gross profit | 67,218 | 46,281 | 45 | 252,055 | 188,561 | 34 | |
Other income | 2 | 10,290 | 18,553 | (45) | 55,381 | 55,808 | (1) |
Finance cost | (4,140) | (5,730) | (28) | (21,371) | (17,409) | 23 | |
Finance income | (1,115) | (875) | 27 | 1,261 | 5,535 | (77) | |
Net finance expense | 3 | (5,255) | (6,605) | (20) | (20,110) | (11,874) | (69) |
Administrative expenses | (13,102) | (15,959) | (18) | (56,811) | (56,703) | 0 | |
Distribution expenses | (21,701) | 14,240 | (252) | (77,955) | (39,040) | 100 | |
Reversal of impairment provision on trade | receivables | 4,319 | 5,634 | (23) | 8,592 | 4,420 | (94) |
Other operating expenses | 4 | (5,079) | (30) | 16,830 | (5,199) | (123) | 4,127 |
Profit before tax | 36,690 | 62,114 | (41) | 155,953 | 141,049 | 11 | |
Income tax expense | (7,433) | (5,561) | (34) | (38,527) | (29,340) | 31 | |
Profit for the period | 29,257 | 56,553 | (48) | 117,426 | 111,709 | 5 | |
Other comprehensive income | |||||||
Items that will not be re-classified to profit or loss | |||||||
Actuarial gain/(loss) on retirement benefit obligation | 26 | (1,953) | (101) | 26 | (1,953) | (101) | |
Income tax on other comprehensive income | (26,296) | (19,551) | 34 | (26,296) | (19,551) | 34 | |
Profit from sale of rights | - | - | - | 16,794 | - | 100 | |
Net gain/(loss) from fair value change of financial assets | (301,094) | 131,578 | (329) | 387,484 | 904,805 | (57) | |
Total other comprehensive income | (327,364) | 110,074 | (397) | 378,008 | 883,301 | (57) | |
Total comprehensive income for the period | (298,107) | 166,627 | (279) | 495,434 | 995,010 | (50) | |
Profit attributable to: | |||||||
Equity holders of the Company | 29,257 | 56,553 | (48) | 117,426 | 111,709 | 5 | |
29,257 | 56,553 | (48) | 117,426 | 111,709 | 5 | ||
Other comprehensive income attributable to: | |||||||
Equity holders of the Company | (327,364) | 110,074 | (397) | 378,008 | 883,301 | (57) | |
(327,364) | 110,074 | (397) | 378,008 | 883,301 | (57) | ||
Earnings per share | |||||||
Basic/Diluted earnings per share (Rs.) | 1.86 | 3.60 | (48) | 7.48 | 7.11 | 5 | |
Figures in brackets indicate deductions. | |||||||
The above figures are provisional & subject to audit. | |||||||
CHEMANEX PLC CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
Quarter ended 31 March | Twelve months ended 31 March | |||||
2025 | 2024 | Variance % | 2025 | 2024 | Variance % | |
(In Rs. '000) Revenue | Note 1 | 240,444 | 224,178 | 7 | 873,516 | 788,965 | 11 |
Cost of sales | (173,226) | (177,897) | (3) | (621,461) | (600,404) | 4 | |
Gross profit | 67,218 | 46,281 | 45 | 252,055 | 188,561 | 34 | |
Other income | 2 | 10,290 | 18,553 | (45) | 55,381 | 55,808 | (1) |
Finance cost | (4,140) | (5,730) | (28) | (21,371) | (17,409) | 23 | |
Finance income | (1,115) | (875) | 27 | 1,261 | 5,535 | (77) | |
Net finance expense | 3 | (5,255) | (6,605) | (20) | (20,110) | (11,874) | (69) |
Administrative expenses | (13,102) | (15,959) | (18) | (56,811) | (56,703) | 0 | |
Distribution expenses | (21,701) | 14,240 | (252) | (77,955) | (39,040) | 100 | |
Reversal of impairment provision on trade receivables | 4,319 | 5,634 | (23) | 8,592 | 4,420 | (94) | |
Other operating expenses | 4 | (5,051) | - | 100 | (5,051) | - | 100 |
Share of loss of equity accounted investees, net of tax | - | - | - | - | - | - | |
Profit before tax | 36,718 | 62,144 | (41) | 156,101 | 141,172 | 11 | |
Income tax expenses | (7,433) | (5,561) | 34 | (38,527) | (29,340) | 31 | |
Profit after tax from continuing operations | 29,285 | 56,583 | (48) | 117,574 | 111,832 | 5 | |
Profit from discontinued operations, net of tax | 392 | (3,171) | (112) | 1,039 | (484) | (315) | |
Profit for the period | 29,677 | 53,412 | (44) | 118,613 | 111,348 | 7 | |
Other comprehensive income | |||||||
Items that will not be re-classified to profit or loss | |||||||
Actuarial loss on retirement benefit obligation | 26 | (1,953) | (101) | 26 | (1,953) | (101) | |
Profit from sale of rights | - | - | - | 16,794 | - | 100 | |
Net gain/(loss) from fair value change of financial assets | (300,914) | 132,181 | (328) | 390,287 | 906,711 | (57) | |
Income tax expense on other comprehensive income | (26,296) | (19,551) | 34 | (26,296) | (19,551) | 34 | |
Other comprehensive income for the period, net of tax | (327,184) | 110,677 | (396) | 380,811 | 885,207 | (57) | |
Total comprehensive income for the period | (297,507) | 164,089 | (281) | 499,424 | 996,555 | (50) | |
Profit attributable to : | |||||||
Equity holders of the Company | 29,715 | 53,415 | (44) | 118,651 | 111,379 | 7 | |
Non-controlling interest | (38) | (3) | 1,167 | (38) | (31) | 23 | |
29,677 | 53,412 | (44) | 118,613 | 111,348 | 7 | ||
Other comprehensive income attributable to : | |||||||
Equity holders of the Company | (327,184) | 110,677 | (396) | 380,811 | 885,207 | (57) | |
Non-controlling interest | - | - | - | - | - | - | |
(327,184) | 110,677 | (396) | 380,811 | 885,207 | (57) | ||
Basic/Diluted earnings per share from continuing operations | (Rs.) | 1.87 | 3.60 | (48) | 7.49 | 7.12 | 5 |
Basic/Diluted earnings per share (Rs.) | 1.89 | 3.40 | (44) | 7.55 | 7.09 | 7 | |
Figures in brackets indicate deductions. | |||||||
The above figures are provisional & subject to audit. |
As at Note | Company | Group | |||||
31 March 2025 | 31 March 2024 | 31 March 2025 | 31 March 2024 | ||||
CHEMANEX PLC STATEMENT OF FINANCIAL POSITION
(In Rs. '000) | ||||||
Non-Current Assets Property, plant & equipment | 13,034 | 19,999 | 13,034 | 19,999 | ||
Intangible assets | 521 | 660 | 521 | 660 | ||
Equity investment at fair value through OCI | 386,469 | 298,844 | 386,469 | 298,844 | ||
400,024 | 319,503 | 400,024 | 319,503 | |||
Current Assets Inventories | 192,514 | 140,046 | 192,514 | 140,046 | ||
Trade and other receivables | 225,506 | 198,098 | 225,506 | 198,098 | ||
Equity investment at fair value through OCI | 3,526,299 | 3,170,694 | 3,526,299 | 3,170,694 | ||
Deposits with banks | 24,473 | 7,466 | 24,473 | 7,466 | ||
Cash & cash equivalents | 5 | 25,156 | 100 | 25,156 | 100 | |
3,993,948 | 3,516,404 | 3,993,948 | 3,516,404 | |||
Assets classified as held for distribution | 47,000 | 47,000 | 64,216 | 59,980 | ||
4,040,948 | 3,563,404 | 4,058,164 | 3,576,384 | |||
Total Assets | 4,440,972 | 3,882,907 | 4,458,188 | 3,895,887 | ||
EQUITY & LIABILITIES Stated capital | 126,250 | 126,250 | 126,250 | 126,250 | ||
Capital reserves | - | - | 3,000 | 3,000 | ||
Revenue reserves | 3,873,158 | 3,416,992 | 3,959,365 | 3,499,171 | ||
Equity attributable to equity holders of the parent | 3,999,408 | 3,543,242 | 4,088,615 | 3,628,421 | ||
Non- controlling interests | - | - | (2,870) | (2,832) | ||
Total Equity | 3,999,408 | 3,543,242 | 4,085,745 | 3,625,589 | ||
Non-Current Liabilities Retirement benefit obligations | 6,775 | 5,815 | 6,775 | 5,815 | ||
Deferred tax liabilities | 37,487 | 8,114 | 37,487 | 8,114 | ||
Current Liabilities | 44,262 | 13,929 | 44,262 | 13,929 | ||
Trade payable | 54,489 | 27,336 | 54,489 | 27,336 | ||
Income tax payable | 22,431 | 7,803 | 22,431 | 7,803 | ||
Accruals & other payable | 111,663 | 117,726 | 41,525 | 47,418 | ||
Loans and borrowings | 208,719 | 172,871 | 208,719 | 172,871 | ||
397,302 | 325,736 | 327,164 | 255,428 | |||
Liabilities classified as held for distribution | - | - | 1,017 | 941 | ||
Total liabilities | 441,564 | 339,665 | 372,443 | 270,298 | ||
Total Equity & Liabilities | 4,440,972 | 3,882,907 | 4,458,188 | 3,895,887 | ||
Net Assets per share (Rs.) | 254.63 | 225.58 | 260.31 | 231.01 | ||
The above figures are provisional & subject to audit. | ||||||
I certify that the above Financial Statements comply with the requirements of the Companies Act No. 7 of 2007.
(Sgd. ) D D Wickramanayake
Chief Financial Officer
The Board of Directors is responsible for these Financial Statements. Signed for and on behalf of the Board by;
(Sgd. ) P R Saldin | (Sgd .) R P Bandaranayake | (Sgd .) S A B P W M R R W T Wegodapola |
Chairman Colombo | Director | Company Secretary |
23rd May 2025 |
CHEMANEX PLC
Stated Capital
Total Equity | ||
Fair Value Reserve | Retained Earnings | |
(In Rs. '000)
Balance as at 01 April 2023 | 126,250 | (47,118) | 2,508,368 | 2,587,500 |
Profit for the period | - | - | 111,709 | 111,709 |
Other comprehensive income | - | 884,668 | (1,367) | 883,301 |
Dividends | - | (39,268) | (39,268) | |
Balance as at 31 March 2024 | 126,250 | 837,550 | 2,579,442 | 3,543,242 |
Balance as at 01 April 2024 | 126,250 | 837,550 | 2,579,442 | 3,543,242 |
Profit for the period | - | - | 117,426 | 117,426 |
Dividends | - | - | (39,268) | (39,268) |
Other comprehensive income | - | 361,196 | 16,812 | 378,008 |
Balance as at 31 March 2025 | 126,250 | 1,198,746 | 2,674,412 | 3,999,408 |
Figures in brackets indicate deductions. The above figures are provisional & subject to audit. |
CHEMANEX PLC
STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 31 MARCH
Stated Capital
Capital Reserves | Revenue Reserves | Total Reserves | Non-Controlling Interest | Total Equity | ||
Reserve on Script Issue | Fair Value Reserve | Retained Earnings | ||||
GROUP
(In Rs. '000)
Balance as at 01 April 2023 | 126,250 | 3,000 | (50,245) | 2,592,098 | 2,671,103 | (2,801) | 2,668,302 |
Profit for the period | - | - | - | 111,379 | 111,379 | (31) | 111,348 |
Dividends | - | - | - | (39,268) | (39,268) | - | (39,268.00) |
Other comprehensive income | - | - | 886,574 | (1,367) | 885,207 | - | 885,207 |
Balance as at 31 March 2024 | 126,250 | 3,000 | 836,329 | 2,662,842 | 3,628,421 | (2,832) | 3,625,589 |
Balance as at 01 April 2024 | 126,250 | 3,000 | 836,329 | 2,662,842 | 3,628,421 | (2,832) | 3,625,589 |
Profit for the period | - | - | - | 118,651 | 118,651 | (38) | 118,613 |
Dividends | - | - | - | (39,268) | (39,268) | - | (39,268) |
Other comprehensive income | - | - | 363,999 | 16,812 | 380,811 | - | 380,811 |
Balance as at 31 March 2025 | 126,250 | 3,000 | 1,200,328 | 2,759,037 | 4,088,615 | (2,870) | 4,085,745 |
Figures in brackets indicate deductions. The above figures are provisional & subject to audit. |
CHEMANEX PLC
CHEMANEX PLC
For the period ended 31 March | 2025 | 2024 | 2025 | 2024 |
Cash flow from operating activities | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 |
Cash generated from operations (Note A) | 93,305 | 127,634 | 96,145 | 124,060 |
Interest paid | (20,709) | (14,541) | (20,709) | (14,541) |
Retirement benefit costs paid | (521) | (635) | (521) | (635) |
Income tax paid | (20,822) | (72,282) | (20,822) | (72,282) |
Net cash inflow from operating activities | 51,253 | 40,176 | 54,093 | 36,602 |
Cash flow from investing activities | ||||
Acquisition of investments | (55,746) | (327,645) | (55,746) | (327,785) |
Addition to property, plant & equipment | (727) | (1,245) | (727) | (1,245) |
Proceeds from disposal of property, plant & equipment | 1,221 | 1,221 | - | |
Dividend received from other companies | 32,398 | 27,169 | 32,398 | 27,169 |
Investment in bank deposits | (17,007) | 123 | (17,007) | 123 |
Disposal of rights | 16,794 | 16,794 | - | |
Interest income received | 952 | 5,535 | 344 | 8,950 |
Net cash outflow from investing activities | (22,115) | (296,063) | (22,723) | (292,788) |
Cash flow from financing activities | ||||
Dividend paid | (39,268) | (39,268) | (39,268) | (39,268) |
Settlement of lease liability | (7,410) | (9,882) | (7,410) | (9,882) |
Net cash outflow from financing activities | (46,678) | (49,150) | (46,678) | (49,150) |
Net decrease in cash & cash | ||||
equivalents during the period | (17,540) | (305,037) | (15,308) | (305,336) |
Cash & cash equivalents at the beginning of the period | (166,023) | 138,425 | (113,111) | 191,636 |
Unrealised exchange loss/(gain) on cash & cash equivalent | - | 589 | - | 589 |
Cash & cash equivalents at the end of the period (Note B) | (183,563) | (166,023) | (128,419) | (113,111) |
Note A - Cash generated from operations | ||||
Profit before tax from continued operations | 155,953 | 141,049 | 156,101 | 141,172 |
Profit before tax from discontinued operations | - | - | 1,048 | (374) |
Adjustments for: | ||||
Depreciation on property, plant & equipment | 1,984 | 2,033 | 1,984 | 2,033 |
Amortization of intangible assets | 139 | 139 | 139 | 139 |
Amortization of right of use of assets | 5,708 | 7,612 | 5,708 | 7,612 |
Gain on disposal of property, plant & equipment | (1,221) | - | (1,221) | - |
Provision for retirement benefit | 1,507 | 1,238 | 1,507 | 1,238 |
Dividend income | (32,398) | (27,169) | (32,398) | (27,169) |
Interest income | (952) | (5,535) | (344) | (8,950) |
Interest expense | 21,371 | 16,820 | 21,371 | 16,820 |
Unrelaised exchange (gain)/loss | - | - | - | |
Operating profit before working capital changes | 152,091 | 136,187 | 153,895 | 132,521 |
Increase in trade and other receivables | (27,408) | (74,943) | (26,618) | (74,966) |
(Increase)/ decrease in inventories | (52,468) | 53,972 | (52,468) | 53,972 |
(Decrease)/ increase in trade and other payables | 21,090 | 12,418 | 21,336 | 12,533 |
Cash generated from operations | 93,305 | 127,634 | 96,145 | 124,060 |
Note B - Analysis of cash & cash equivalents at the end of the year | ||||
Cash in hand, at bank and investment in government securities | 25,156 | 100 | 80,300 | 53,012 |
Interest bearing short-term borrowings | (208,719) | (166,123) | (208,719) | (166,123) |
(183,563) | (166,023) | (128,419) | (113,111) | |
Figures in brackets indicate deductions. | ||||
The above figures are provisional & subject to audit. |
CHEMANEX PLC SEGMENT INFORMATION
Note 1For the period ended 31 March | Group | |
2025 | 2024 | |
(In Rs. '000) | ||
(a) Industry segment revenue | ||
Rubber and plastic | 440,806 | 379,161 |
Coating and packaging | 293,025 | 307,863 |
Home and personal care | 139,685 | 101,941 |
Total revenue from external customers | 873,516 | 788,965 |
PROFIT BEFORE TAXATION | ||
(In Rs. '000) | ||
(b) Industry segment | ||
Rubber and plastic | 98,792 | 62,198 |
Coating and packaging | 22,854 | 41,655 |
Home and personal care | 6,613 | 997 |
128,259 | 104,850 | |
Unallocated expenses | (7,429) | (7,612) |
Other income | 55,381 | 55,808 |
Finance income/ (cost) (net) | (20,110) | (11,874) |
Income tax expense | (38,527) | (29,340) |
Profit from discontinued operations | 1,039 | (484) |
118,613 | 111,348 | |
The above figures are provisional & subject to audit. | ||
Figures in brackets indicate deductions. | ||
CHEMANEX PLC
2024
20252024
2025Group
Company
(In Rs. '000) | |||||
2 | Other income | ||||
Dividend income | 32,398 | 27,169 | 32,398 | 27,169 | |
Direct sales commission | 14,027 | 13,224 | 14,027 | 13,224 | |
Rent income | 7,696 | 15,249 | 7,696 | 15,249 | |
Profit from disposal of property, plant & equipment | 1,221 | - | 1,221 | - | |
Sundry income | 39 | 166 | 39 | 166 | |
55,381 | 55,808 | 55,381 | 55,808 | ||
3 | Net finance income | Company | Group | ||
For the period ended 31 March | 2025 2024 | 2025 | 2024 | ||
(In Rs. '000) | |||||
Interest income on deposits | 952 5,535 | 952 | 5,535 | ||
Gain on foreign currency | 309 - | 309 | - | ||
Finance cost (Note 3.1) | (21,371) (17,409) | (21,371) | (17,409) | ||
(20,110) (11,874) | (20,110) | (11,874) |
3.1 | Finance cost | Company | Group | ||
For the period ended 31 March | 2025 2024 | 2025 | 2024 | ||
(In Rs. '000) Interest on short-term loans & overdrafts | 20,709 14,317 | 20,709 | 14,317 | ||
Interest on lease | 662 2,868 | 662 | 2,868 | ||
Loss on foreign currency | - 224 | - | 224 | ||
21,371 17,409 | 21,371 | 17,409 |
4 | Other operating expenses | Company | Group | ||
For the period ended 31 March | 2025 2024 | 2025 | 2024 | ||
(In Rs. '000) Provision for inter- company receivables | 148 123 | - | - | ||
Provision for the advance given to Rainforest Ecolodge (Private) Limited | 5,051 - | 5,051 | - | ||
5,199 123 | 5,051 | - |
5 | Cash and Cash equivalents | Company | Group | ||
For the period ended 31 March | 2025 2024 | 2025 | 2024 | ||
(In Rs. '000) Cash and bank - Local Currency | 25,156 100 | 25,156 | 100 | ||
25,156 100 | 25,156 | 100 | |||
Loans & borrowings | (192,580) (105,200) | (192,580) | (105,200) | ||
Bank overdrafts | (16,139) (60,923) | (16,139) | (60,923) | ||
Cash & Cash equivalents classified as held for sale and distribution | - | 55,144 | 52,912 | ||
Cash & Cash equivalents for cash flow purpose | (183,563) (166,023) | (128,419) | (113,111) |
2025 31-Mar | 2024 31-Mar | |||||||
Highest | Rs. 189.00 | Rs. 75.50 | ||||||
Lowest | 146.25 | 65.00 | ||||||
Last traded | 154.00 | 72.00 | ||||||
7 | Earnings and net assets per share | Company | Group | |||||
For the period ended 31 March | 2025 | 2024 | 2025 | 2024 | ||||
Basic earnings per share (Rs.) | 7.48 | 7.11 | 7.55 | 7.09 | ||||
Net assets per share (Rs.) | 254.63 | 225.58 | 260.31 | 231.01 | ||||
8 Share trading | ||||||||
For the period ended 31 March | 2025 | 2024 | ||||||
31-Mar | 31-Mar | |||||||
No of transactions during the period | 1,782 | 254 | ||||||
No of shares traded during the period | 878,027 | 172,695 | ||||||
Value of shares traded during the period (Rs.000) | 149,282,277 | 11,840,350 | ||||||
9 Stated capital | ||||||||
2025 | 2024 | |||
No of shares ('000) | Value Rs.000 | No of shares ('000) | Value Rs.000 | |
2023
2024As at 31 March 15,707 126,250 15,707 126,250
10 Rs. Rs.Final 11 Directors' shareholding as at 31 March 2025 | 2.50 | 2.50 |
As at the reporting date no Directors had shares of the Company together with their spouses. | ||
12 Twenty largest shareholders | 31.03.2025 | 31.03.2025 |
Name of the shareholder | No of shares | % |
CIC Holdings PLC | 7,939,373 | 50.55 |
CIC Holdings PLC/ Charitable & Education Trust Fund | 1,627,383 | 10.36 |
Sakuvi Investment Trust (Private) Limited | 538,366 | 3.43 |
Hatton National Bank PLC/ Mr. W. Jinadasa | 456,467 | 2.91 |
CIC Agri Businesses (Private) Limited | 446,604 | 2.84 |
S.K. Wickremesinghe Trust (Guarantee) Limited | 400,000 | 2.55 |
Estate of Late Mr. S.K. Wickremesinghe (Deceased) | 315,245 | 2.01 |
Mr. S. Srikanthan & Mrs. S. Srikanthan | 300,000 | 1.91 |
Senkadagala Finance PLC/ Mr. L.A.J.F. Morais | 124,051 | 0.79 |
Senkadagala Finance PLC/ Mr. M. Siridaran | 109,773 | 0.70 |
Mr. B.T. De S. Weerasooria | 101,055 | 0.64 |
Mr. D.A. De Zoysa | 100,000 | 0.64 |
DFCC Bank PLC/ Mr. P. Pranavan | 100,000 | 0.64 |
Mr. M.J. Ismail | 97,148 | 0.62 |
Senkadagala Finance PLC/ Mr. L.L. Fernando & D.S. Fernando | 85,000 | 0.54 |
Bensons Limited | 83,286 | 0.53 |
Mrs. M.C. Abeysekera (Deceased) | 81,546 | 0.52 |
Mr. R.C.D. De Silva | 75,000 | 0.48 |
Mrs. T.T.A. De Silva Weerasooria | 75,000 | 0.48 |
Mr. H.R. Peries | 72,500 | 0.46 |
13,127,797 | 83.58 |
Notes to the Financial Statements (Cont..) | |||
13 Public Holding | 31.03.2025 | 31.03.2025 | |
No of shares | % | ||
Parent company & related companies | |||
CIC Holdings PLC | 7,939,373 | 50.55 | |
CIC Trustees for Charitable & Educational Trust Fund | 1,627,383 | 10.36 | |
CIC Agri Businesses (Private) Limited | 446,604 | 2.84 | |
10,013,360 | 63.75 | ||
Public holding | 5,693,952 | 36.25 | |
15,707,312 | 100.00 | ||
13.1 Public Holding | |||
Ordinary shares of the Company held by public as at 31 March 2025 were as follows : | |||
Number of Public Shareholders | 1,369 | ||
Percentage of public holding | 36.25% | ||
14 Market Capitalization | Capitalization | ||
No of shares | Share price Rs. | Rs. | |
Ordinary shares | 15,707,312 | 154.00 | 2,418,926,048 |
15 Float Adjusted Market Capitalization | |||
Capitalization | |||
No of shares | Share price Rs. | Rs. | |
Shares held by public | 5,693,952 | 154.00 | 876,868,608 |
As the float adjusted market capitalisation is below Rs.2.5 Bn, Chemanex PLC complies under option 5 with the minimum public holding requirement.
The accounting policies followed in the preparation of the Interim Statement of Comprehensive Income for the period ended 31 March 2025 and the Interim Statement of Financial Position as at 31 March 2025 unless otherwise stated are consistent with those followed in the preparation of Financial Statements for the year ended 31 March 2024 and are in compliance with Sri Lanka Accounting Standard 34 - Interim Financial Reporting. The presentation and classification of the Financial Statements of the previous period have been amended, where relevant, for better presentation and to be comparable with those of the current period.
Fair value measurement and related fair value disclosures
As at 31 March 2025, all the listed equity instruments amounting to Rs.3,526.30Mn were measured based on the active market prices as at 31 March 2025 and categorised under Level 1 of the fair value hierarchy.
Based on the fair valuation methodology, other non- current equity investment at fair value though OCI amounting to Rs.386.47 Mn is categorised under "Level 3" of the "fair value measurement hierarchy". Fair value would not significantly vary if one or more of the inputs were changed.
There are no material contingent liabilities as at the reporting date, which require adjustment and/or disclosure in the Financial Statements.
There were no material events have been taken place as at the reporting date which require adjustments to ot disclosures in the Financial Statements.